Dr. Michael Heke, Ph.D. will drive integration of exosome-based topical cosmetics, regenerative biotherapeutics medical and scientific intelligence, and as well as aspects of patient safety as Managing Director-Scientific Officer.
Rochester, NY, February 8, 2023 — The Crowley Center™ for Regenerative & Biotherapeutics, LLC (aka AT Venture Center™, LLC) today announced that Dr. Heke has been appointed as Chief Scientific Officer of The Crowley Center, and its subsidiaries, Regenerelle™ Cellular & Exosome Biotherapeutics, Resiliélle™ Exosome Cosmetics, Sanatela® Regenerative Medical, Sanatela® AT Medical Solutions, Sanatela® Precision Cancer Diagnostics, Sanatela® Animal Biotechnologies, Sanatela® Biotechnologies, Sanatela® Matrix, Sanatela® Life Sciences and AT Venture Center for Global Techtrepreneurship™. Regenerelle’s and Sanatela’s IP technologies are both Patent Pending. [Read more…]